首頁
Teva Pharmaceuticals

11月 2025Teva Pharmaceuticals的市場佔有率分析

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform.

行業: N/A

域名tevapharm.in

成立年份1901

僱員> 10001

年度營收> $1B

Teva Pharmaceuticals

Teva Pharmaceuticals（包含公司地區）

tevapharm.in

查看更多網站流量與參與度資訊

Teva Pharmaceuticals截至 11月 2025 的總收入為 > 1B

Teva Pharmaceuticals 熱門網域產生的總收入

Teva Pharmaceuticals 熱門網域 3 年內的總收入

Teva Pharmaceuticals 熱門網域的總收入

tevapharm.in> 1B

透過銷售情報查看更多內容

11月 2025Teva Pharmaceuticals的股票價格

Teva Pharmaceuticals 股票交易代碼 #TEVA。以下是截至 11月 2025Teva Pharmaceuticals 過去 12 個月的股票績效

Teva Pharmaceuticals的熱門網域總造訪量

了解Teva Pharmaceuticals市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

tevapharm.in2.6K

透過銷售情報查看更多內容

Teva Pharmaceuticals的熱門網域平均造訪時長

分析Teva Pharmaceuticals參與度指標。

過去 3 個月平均造訪時長

子公司細目

tevapharm.in00:00:31

透過銷售情報查看更多內容

Teva Pharmaceuticals的熱門網域平均頁面瀏覽量

了解Teva Pharmaceuticals如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

tevapharm.in1.87

透過銷售情報查看更多內容

Teva Pharmaceuticals按網域劃分的熱門競爭對手

11月 2025的熱門類似網站，依相似度排名

tapi.com公司名TAPI僱員1001 - 5000總部以色列, Petah Tikva年度營收$25M - $50M訪問總量8.5K健康 > 生物技術和製藥

使用的熱門技術Teva Pharmaceuticals

这些是Teva Pharmaceuticals顶级域名使用的行业网站技术

轉換與分析 (3)

Google Analytics

行動裝置 (2)

Meta Viewport

付費廣告 (1)

PubMatic

倡議 (1)

Cision

更多技術

5

檢視所有

新聞與訊號來自Teva Pharmaceuticals

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Takeda Pharmaceuticals partnered with Tevapharm on Jul 1st '20.For instance, in July 2020, Takeda Pharmaceutical Company Limited, a Japanese multinational pharmaceutical company, entered into a joint venture with Teva Pharmaceutical Industries Ltd., an Israeli multinational pharmaceutical company to focus on the commercialization of complex generics, specialty assets, and other pipeline opportunities.

新聞Tevapharm has issues with federal antitrust litigation over claims that it illegally pledged to stay out of the generic EpiPen market if two competing drugmakers delayed generic versions of the narcolepsy treatment Nuvigil.COMPANY INFO: Teva Pharmaceutical Industries Ltd. (Bloomberg Law Subscription) Teva Pharmaceutical Industries Ltd. is facing federal antitrust litigation over claims that it illegally pledged to stay out of the generic EpiPen market if two competing drugmakers delayed generic versions of the narcolepsy treatment Nuvigil.

新聞Tevapharm sells assets to Marksans Pharma Limited.Marksans Pharma in a filing to exchanges said the company will acquire Teva Pharma’s business relating to the manufacture and supply of bulk pharmaceutical formulations in Plot No.